ENO1 and cancer: Mechanistically, we have provided the axis of ENO1-AMPK-Akt that controls the cancer-like PASMC phenotypes characterized by increased cell proliferation, de-differentiation, apoptosis resistance, and metabolic shift to glycolysis.